Country: Portugall
Lingwa: Ingliż
Sors: HMA (Heads of Medicines Agencies)
milbemycin A<3>-oxim 2.5 mg, praziquantel 25 mg
NOVARTIS SA
QP54AB51
Chewable tablet
Milbemycin, combinations
Dogs
2011-07-09
SUMMARY OF PRODUCT CHARACTERISTICS MILBEMAX chewable tablets for small dogs and puppies Summary of Product Characteristics Novartis Animal Health Inc. CONFIDENTIAL Page 2 of 7 1. NAME OF THE VETERINARY MEDICINAL PRODUCT MILBEMAX chewable tablets for small dogs and puppies SE: Milbemax vet. chewable tablets for small dogs and puppies 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One chewable tablet contains: ACTIVE SUBSTANCES: Milbemycin oxime 2.5 mg Praziquantel 25.0 mg EXCIPIENTS: Glycerol (E422) 92.12 mg Propylene glycol (E 1520) 0.91 mg Iron oxide, brown (E 172) 0.66 mg Butylhydroxyanisole (E 320) 0.26 mg Propyl gallate (E 310) 0.09 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Chewable tablet Oval shaped, dark brown. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In dogs : treatment of mixed infections by adult cestodes and nematodes of the following species: - Cestodes: _Dipylidium caninum _ _Taenia spp. _ _Echinococcus spp. _ _Mesocestoides spp. _ - Nematodes: _Ancylostoma caninum _ _Toxocara canis _ _Toxascaris leonina _ _Trichuris vulpis _ _Crenosoma vulpis_ (Reduction of the level of infection)_ _ MILBEMAX chewable tablets for small dogs and puppies Summary of Product Characteristics Novartis Animal Health Inc. CONFIDENTIAL Page 3 of 7 _Angiostrongylus vasorum_ (Reduction of the level of infection) (see specific treatment schedule under section 4.9 “Amounts to be administered and administration route”)_ _ _ _ The product can also be used in the preventi Aqra d-dokument sħiħ
SUMMARY OF PRODUCT CHARACTERISTICS MILBEMAX chewable tablets for small dogs and puppies 25-Sep-2009 Summary of Product Characteristics (MRP Day 85) Novartis Animal Health Inc. CONFIDENTIAL Page 2 of 7 1. NAME OF THE VETERINARY MEDICINAL PRODUCT MILBEMAX chewable tablet for small dogs and puppies SE: Milbemax vet. chewable tablet for small dogs and puppies 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One chewable tablet contains: ACTIVE SUBSTANCES: Milbemycin oxime 2.5 mg Praziquantel 25.0 mg EXCIPIENTS: Glycerol (E422) 92.12 mg Propylene glycol (E 1520) 0.91 mg Iron oxide, brown (E 172) 0.66 mg Butylhydroxyanisole (E 320) 0.26 mg Propyl gallate (E 310) 0.09 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Chewable tablet Oval shaped, dark brown. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In dogs : treatment of mixed infections by adult cestodes and nematodes of the following species: - Cestodes: _Dipylidium caninum _ _Taenia spp. _ _Echinococcus spp. _ _Mesocestoides spp. _ - Nematodes: _Ancylostoma caninum _ _Toxocara canis _ _Toxascaris leonina _ _Trichuris vulpis _ _Crenosoma vulpis_ (Reduction of the level of infection)_ _ MILBEMAX chewable tablets for small dogs and puppies 25-Sep-2009 Summary of Product Characteristics (MRP Day 85) Novartis Animal Health Inc. CONFIDENTIAL Page 3 of 7 _Angiostrongylus vasorum_ (Reduction of the level of infection) (see specific treatment schedule under section 4.9 “Amounts to be administered and administration route”)_ _ _ _ The Aqra d-dokument sħiħ